Statement on research into single embryo transfer
22 December 2010
Research published in the British Medical Journal shows women who have one embryo transferred during IVF treatment are five times more likely to give birth to a healthy baby than those who receive two embryos.
Multiple pregnancies are the single biggest risk of IVF to both mother and babies yet are entirely avoidable. We are working with the professional bodies and patients groups to promote the birth of a single healthy baby as the best outcome of fertility treatment.
This research adds to the growing weight of evidence that supports single embryo transfer as the best policy in defined circumstances.
The Authority has set a target of no more than 15% multiple births by April 2012. This research shows it is an achievable target and will protect both mothers and babies born as a result of IVF whilst continuing to give good success rates.
Ends
Notes to editors
- British Medical Journal abstract http://www.bmj.com/content/341/bmj.c6945.abstract
- The HFEA is the independent regulator for IVF treatment and embryo research. Our role is to protect patients and the public interest, to drive improvement in the treatment and research sectors and to provide information to the public and policymakers about treatment and research.
- The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA’s principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), artificial insemination (AI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos.
Page last updated: 22 December 2010